[Seminar] "Pharmaceutical Patent Strategy" Considering the Pharmaceutical and Medical Device Act
~Practical responses based on patent linkage, re-examination system, and patent disputes~
Our company will hold a business seminar. 【Practical Insights Gained from the Seminar】 - Strategic optimization through the interlinked design of the Pharmaceutical and Medical Device Act and patent examination/approval review - Risk avoidance strategies for patent disputes considering patent linkage - Practical strategies for pharmaceutical lifecycle management utilizing the re-examination system 【Target Industries and Departments】 - Intellectual property departments and patent strategy personnel of pharmaceutical companies - Regulatory affairs, approval application, and development departments of pharmaceuticals - Legal and compliance departments in the life sciences field - Personnel in law firms and patent offices specializing in pharmaceuticals 【Seminar Details】 ■ Date and Time: July 29, 2026 (Wednesday) 13:30 - 16:00 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Instructor: Professor Hiroshi Kato, Nihon University Graduate School (Patent Attorney) *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
[Course Overview] In recent years, as the importance of intellectual property has increased, there have been notable instances where the Pharmaceuticals and Medical Devices Act (PMDA) has impacted patent practices in the pharmaceutical field. As a result, there is a growing demand for the development of pharmaceutical patent strategies that take into account the practical aspects of the PMDA. Additionally, there is a noticeable trend of patent disputes in the pharmaceutical sector, leading to increased attention on patent linkage as a means to prevent patent infringement. Recently, there has been a call for the establishment of pharmaceutical patent strategies that consider patent linkage. In this lecture, we will organize the recent amendments to the PMDA from this perspective and explain new viewpoints on pharmaceutical patent strategies that take patent linkage into account, as well as discuss future challenges and countermeasures. [Lecture Topics] ■ Current status and challenges of patent law and the PMDA ■ The relationship between the re-examination system for pharmaceuticals and patents ■ Current status and challenges of patent linkage ■ The effectiveness of patent rights and the practical aspects of the PMDA ■ New perspectives on pharmaceutical patent strategies considering the practical aspects of the PMDA ■ Related Q&A ■ Business card and information exchange session
Price information
[Participation Fee] 1 person: 37,200 yen (tax included) From 2 people onwards: 32,200 yen (tax included / same organization, simultaneous application) *For those affiliated with local public organizations, up to 2 people can participate for 11,000 yen (tax included / venue and live streaming only)
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
